Skip to content
Screener

Guardian Pharmacy Services GRDN Q1 2026 earnings

Reported May 6, 2026 · After market close

Revenue$336.6MBeat by $6.7M
EPS$0.29Beat by $0.05
Revenue estimate$329.9M
EPS estimate$0.24

Next report

Date not yet announced

Financials

Q1 2026

Income statement

See full
Revenue$336.6M+2.2%
Gross profit$76.3M+18.6%
Operating income$17.7M+35.9%
Net income$13.3M+40.7%
EPS (diluted)$0.21+40.0%

Balance sheet

See full
Cash & equivalents$64.9M+364%
Total debt$36.9M+29.6%
Total equity$232.4M+42.4%
Total assets$426.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M-65.5%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$2.42B+80.1%
Enterprise value$2.4B+76.1%
P/E45.7×—
P/S1.7×+0.6×

Profitability

See full
Gross margin20.9%+1.1pp
Operating margin5.3%—
Net margin3.6%+2.1pp

Returns & leverage

See full
Return on equity26.8%—
Debt / equity0.2×0.0×
Current ratio1.5×+0.3×

Segments

By segment

See full
Corporate$336.6M+2.2%

FAQ

When did Guardian Pharmacy Services report Q1 2026 earnings?
Guardian Pharmacy Services (GRDN) reported Q1 2026 earnings on May 6, 2026 after market close.
What were Guardian Pharmacy Services's Q1 2026 revenue and EPS?
Guardian Pharmacy Services reported revenue of $336.6M and eps of $0.29 for Q1 2026.
Did Guardian Pharmacy Services beat estimates in Q1 2026?
Revenue beat the consensus estimate of $329.9M by $6.7M. EPS beat the consensus estimate of $0.24 by $0.05.
How did Guardian Pharmacy Services's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.2% from $329.3M a year earlier and eps grew 38.1% from $0.21.
Where can I find Guardian Pharmacy Services's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-208989) and the 10-Q periodic report (0001193125-26-209021) directly on SEC EDGAR. The filing index links above go to sec.gov.